Floatz logo

215 assets in Castration-Resistant Prostate Carcinoma

Therapeutic assets addressing Castration-Resistant Prostate Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Janx007
Castration-Resistant Prostate Carcinoma
Janux TherapeuticsP1CC (43)
Jnj-101556143
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (43)
Ktx-2001
Castration-Resistant Prostate Carcinoma
K36 Therapeutics, Inc.P1CC (43)
lu 177-psma-3d1015
Castration-Resistant Prostate Carcinoma
Chunjing YuP1CC (43)
MGC026
Castration-Resistant Prostate Carcinoma
MacroGenicsP1CC (43)
Nezastomig
Castration-Resistant Prostate Carcinoma
Regeneron PharmaceuticalsP1/2CC (43)
Nuv-1511
Castration-Resistant Prostate Carcinoma
Nuvation Bio Inc.P1/2CC (43)
Nuv-868
Castration-Resistant Prostate Carcinoma
Nuvation Bio Inc.P1CC (43)
Pidnarulex
Castration-Resistant Prostate Carcinoma
Peter MacCallum Cancer Centre, AustraliaP1CC (43)
Regn15505
Castration-Resistant Prostate Carcinoma
Regeneron PharmaceuticalsP1/2CC (43)
Regn4336
Castration-Resistant Prostate Carcinoma
Regeneron PharmaceuticalsP1/2CC (43)
Triprorelin For
Castration-Resistant Prostate Carcinoma
The Affiliated Hospital of Qingdao UniversityP1CC (43)
TSL2109
Castration-Resistant Prostate Carcinoma
Tasly Pharmaceutical Group Co., LtdP1CC (43)
ty-302
Castration-Resistant Prostate Carcinoma
TYK Medicines, IncP1/2CC (43)
Vancomycin
Castration-Resistant Prostate Carcinoma
Institute of Cancer Research, United KingdomP1/2CC (43)
Vandazole
Castration-Resistant Prostate Carcinoma
Institute of Cancer Research, United KingdomP1/2CC (43)
Vir-5500
Castration-Resistant Prostate Carcinoma
Vir Biotechnology, Inc.P1CC (43)
Vudalimab
Castration-Resistant Prostate Carcinoma
Xencor, Inc.P2CC (43)
Utomilumab
Castration-Resistant Prostate Carcinoma
M.D. Anderson Cancer CenterP1/2CC (42)
161Tb-SibuDAB
Castration-Resistant Prostate Carcinoma
University Hospital, Basel, SwitzerlandP1CC (41)
Dcc-2812
Castration-Resistant Prostate Carcinoma
Deciphera Pharmaceuticals, LLCP1CC (41)
Denifanstat
Castration-Resistant Prostate Carcinoma
Weill Medical College of Cornell UniversityP1CC (41)
ide034
Castration-Resistant Prostate Carcinoma
IDEAYA BiosciencesP1CC (41)
Immunoglobulin G4, Anti-(Human Cd3 Antigen) (Recombinant Human Monoclonal Jnj-75348780 ?4-Chain), Disulfide With Recombinant Human Monoclonal Jnj-75348780 ? Chain, (229?126?),(232?129?)-Bis(Disulfide) With Immunoglobulin, Anti-(Human Sialic Acid-Binding Ig-Like Lectin 2) (Recombinant Human Single-Domain Vhh Fragment)
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (41)
Janx014
Castration-Resistant Prostate Carcinoma
Janux TherapeuticsP1CC (41)
Jnj-54179060
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (41)
Jnj-56021927
Castration-Resistant Prostate Carcinoma
Aragon Pharmaceuticals, Inc.P1CC (41)
Jnj-64264681
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (41)
Jnj-64619178
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (41)
Jnj-70218902
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (41)
Jnj-74856665
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (41)
Jnj-80948543
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (41)
Jnj-87801493
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (41)
Panitumumab
Castration-Resistant Prostate Carcinoma
Biosplice Therapeutics, Inc.P1CC (41)
Psma I&T
Castration-Resistant Prostate Carcinoma
National Taiwan University HospitalP1CC (41)
Psma-Ucar T
Castration-Resistant Prostate Carcinoma
Shanghai Changzheng HospitalP1CC (41)
Rosuvastatin
Castration-Resistant Prostate Carcinoma
Aragon Pharmaceuticals, Inc.P1CC (41)
Safimaltib
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLCP1CC (41)
sm08502
Castration-Resistant Prostate Carcinoma
Biosplice Therapeutics, Inc.P1CC (41)
111in-abd147
Castration-Resistant Prostate Carcinoma
Thomas HopeEarly P1C (39)
11C-YJH08
Castration-Resistant Prostate Carcinoma
Rahul AggarwalP1C (39)
18f-trx
Castration-Resistant Prostate Carcinoma
Rahul AggarwalP1C (39)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Castration-Resistant Prostate Carcinoma
Nurix Therapeutics, Inc.P1C (39)
Anti-Psma Car-Nk
Castration-Resistant Prostate Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
Autologous Anti-Psca-Car-4-1Bb/Tcrzeta-Cd19T-Expressing T-Lymphocytes
Castration-Resistant Prostate Carcinoma
City of Hope Medical CenterP1C (39)
Cedazuridine
Castration-Resistant Prostate Carcinoma
Roswell Park Cancer InstituteP1C (39)
Fluorouracilum
Castration-Resistant Prostate Carcinoma
Biosplice Therapeutics, Inc.P1C (39)
Gx-I7
Castration-Resistant Prostate Carcinoma
SL VAXiGENP1C (39)
inr731
Castration-Resistant Prostate Carcinoma
Novartis PharmaceuticalsP1C (39)
Lutetium Dgul
Castration-Resistant Prostate Carcinoma
Cellbion Co., Ltd.P1C (39)
Showing 151 to 200 of 215 assets
PreviousPage 4 of 5Next